LLY
1,017.37
+2.97%↑
JNJ
210.11
+3.05%↑
ABBV
222.93
+0.05%↑
UNH
338.12
+4.2%↑
AZN
90.93
+0.98%↑
LLY
1,017.37
+2.97%↑
JNJ
210.11
+3.05%↑
ABBV
222.93
+0.05%↑
UNH
338.12
+4.2%↑
AZN
90.93
+0.98%↑
LLY
1,017.37
+2.97%↑
JNJ
210.11
+3.05%↑
ABBV
222.93
+0.05%↑
UNH
338.12
+4.2%↑
AZN
90.93
+0.98%↑
LLY
1,017.37
+2.97%↑
JNJ
210.11
+3.05%↑
ABBV
222.93
+0.05%↑
UNH
338.12
+4.2%↑
AZN
90.93
+0.98%↑
LLY
1,017.37
+2.97%↑
JNJ
210.11
+3.05%↑
ABBV
222.93
+0.05%↑
UNH
338.12
+4.2%↑
AZN
90.93
+0.98%↑
24h
Current
Min
2.14
Max
2.26
Recommendations | Buy |
|---|---|
12 Months Forecast | +236.24% upside |
By Acuity
50%
50%
195 / 374 Ranking in Healthcare
By Trading Central
Confidence
Bullish Evidence
1.76 / 1.94 Support & Resistance
Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.
10 gru 2025, 22:02 UTC
Synopsys Sees Strong 2026 as Ansys Acquisition Boosts 4Q Revenue
DJ
Read
10 gru 2025, 21:46 UTC
Adobe Expects Double-Digit Recurring Revenue Growth Next Year
DJ
Read
10 gru 2025, 23:52 UTC
Paramount Sends Letter to Warner Bros. Shareholders Saying Its Offer Is 'Superior' -- Barrons.com
DJ
Read
10 gru 2025, 23:43 UTC
Nikkei May Rise After Fed Rate Cut -- Market Talk
DJ
Read
10 gru 2025, 23:36 UTC
Gold Consolidates as Traders Digest FOMC Decision -- Market Talk
DJ
Read
10 gru 2025, 23:20 UTC
Oracle Reports $16.1 Billion in Revenue, Narrowly Missing Forecasts -- 2nd Update
DJ
Read
10 gru 2025, 23:15 UTC
Synopsys Targets Double-Digit Growth Following Ansys Acquisition -- Interview
DJ
Read
10 gru 2025, 22:59 UTC
Adobe Expects Semrush Deal to Bring in New Users -- Market Talk
DJ
Read
10 gru 2025, 22:45 UTC
Coca-Cola's New CEO Pick Looks A Lot Like The Last One -- Market Talk
DJ
Read
10 gru 2025, 22:40 UTC
Synopsys Stock Rises on Earnings Beat, Higher Guidance -- Barrons.com
DJ
Read
10 gru 2025, 22:06 UTC
Paramount Sends Letter to Warner Bros. Shareholders Saying Their Offer Is 'Superior' -- Barrons.com
DJ
Read
10 gru 2025, 22:06 UTC
Oracle Reports Mixed Earnings. The Stock Is Falling. -- Barrons.com
DJ
Read
10 gru 2025, 22:02 UTC
Synopsys Stock Rises on Earnings Beat, Higher Guidance -- Barrons.com
DJ
Read
10 gru 2025, 22:00 UTC
Oracle Reports $16.1 Billion in Revenue, Narrowly Missing Forecasts -- Update
DJ
Read
10 gru 2025, 21:53 UTC
Adobe Earnings Show 'Rapid Adoption' of AI Tools. The Stock Is Up. -- Barrons.com
DJ
Read
10 gru 2025, 21:50 UTC
Investors Bet That a Higher Bid for Warner Is Coming -- Update
DJ
Read
10 gru 2025, 21:50 UTC
Financial Services Roundup: Market Talk
DJ
Read
10 gru 2025, 21:50 UTC
Health Care Roundup: Market Talk
DJ
Read
10 gru 2025, 21:50 UTC
Auto & Transport Roundup: Market Talk
DJ
Read
10 gru 2025, 21:45 UTC
Paramount Sends Letter to Warner Bros. Shareholders Saying Their Offer Is 'Superior' -- Barrons.com
DJ
Read
10 gru 2025, 21:33 UTC
Oracle Reports $16.1 Billion in Revenue, Narrowly Missing Forecasts -- WSJ
DJ
Read
10 gru 2025, 21:32 UTC
Oracle Reports Mixed Earnings. The Stock Is Falling. -- Barrons.com
DJ
Read
10 gru 2025, 21:28 UTC
Sverica Capital Management Announces Sale of Coastal Cloud Holdings to Tata Consultancy Services for $700M
DJ
Read
10 gru 2025, 21:25 UTC
Adobe Earnings Show 'Rapid Adoption' of AI Tools. The Stock Is Up. -- Barrons.com
DJ
Read
10 gru 2025, 21:18 UTC
Paramount Skydance: Company Has Air Tight Financing to Deliver on Warner Bros. Offer >PSKY
DJ
Read
10 gru 2025, 21:16 UTC
Oracle Reports Mixed Earnings. The Stock is Falling. -- Barrons.com
DJ
Read
10 gru 2025, 21:15 UTC
Paramount Skydance: Public Offer for Warner Bros. Delivers Superior Value, Faster, More Certain Path to Completion
DJ
Read
10 gru 2025, 21:15 UTC
Oracle: 'Sold Ampere Because We No Longer Think It Is Strategic for Us to Continue Designing, Manufacturing and Using Our Own Chips in Our Cloud Datacenters' >ORCL
DJ
Read
10 gru 2025, 21:14 UTC
Oracle 2Q Non-GAAP Operating Income Was $6.7 B >ORCL
DJ
Read
10 gru 2025, 21:14 UTC
Oracle 2Q GAAP Operating Income Was $4.7 B >ORCL
DJ
Read
Price change
By TipRanks
12 Months Forecast
Average 7.33 USD 236.24%
High 13 USD
Low 3 USD
Based on 3 Wall Street analysts offering 12 month price targets forInovio Pharmaceuticals Inc - Dist in the last 3 months.
By TipRanks
Buy
3 ratings
2
Buy
1
Hold
0
Sell
Based on 3 analysts giving stock ratings to Inovio Pharmaceuticals Inc - Dist in the past 3 months.
By Trading Central
Short Term
Bullish Evidence
Recent bullish events outweigh bearish events.
Intermediate Term
Strong Bullish Evidence
Recent bullish events outweigh bearish events.
Long Term
No Evidence
There are no events.
By Acuity
News Sentiment
Neutral
Volatility
Below average
News Volume (RCV)
Below average
$